To adjuvant chemotherapy after curative treatment of head and neck cancer A study of alternate-day administration definitive TS-1
Not Applicable
- Conditions
- Head and neck cancer
- Registration Number
- JPRN-UMIN000009856
- Lead Sponsor
- ational Center for Global health and Medicine Otolarygology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1)It is contraindicated in patients with the administration of TS-1 2)Cases that are complicated by infection requiring treatment 3)Gastrointestinal disease with treatment (intestinal paralysis, intestinal obstruction, etc.) Patients with 4)Patients with interstitial pneumonitis or pulmonary fibrosis 5)Patients with diabetes 6)Patients with heart disease 7)Patients with (watery) diarrhea 8)Patients attending physician was deemed inappropriate as the subject of the study for other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Completion percentage administration
- Secondary Outcome Measures
Name Time Method Adverse event, Total dose for dose planning ,survival, recurrence-free survival